The role of mitochondria in insulin resistance and type 2 diabetes mellitus (Q37930956)

25 August 2017

1 reference

title

The role of mitochondria in insulin resistance and type 2 diabetes mellitus (English)

1 reference

25 August 2017

0 references

1 reference

1 reference

1 reference

3

Michael Roden

1 reference

25 August 2017

1

Julia Szendroedi

1 reference

25 August 2017

Esther Phielix

2

1 reference

25 August 2017

13 September 2011

1 reference

Nature Reviews Endocrinology

25 August 2017

1 reference

25 August 2017

8

1 reference

25 August 2017

92-103

1 reference

25 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2011.138

25 August 2017

0 references

cites work

Non-invasive studies of glycogen metabolism in human skeletal muscle using nuclear magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Mitochondrial fitness and insulin sensitivity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Mitochondrial dysfunction and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Mitochondrial metabolic function assessed in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

The interpretation of abnormal 31P magnetic resonance saturation transfer measurements of Pi/ATP exchange in insulin-resistant skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Muscle insulin resistance: a case of fat overconsumption, not mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Skeletal muscle "mitochondrial deficiency" does not mediate insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Mitochondria and diabetes mellitus: untangling a conflictive relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Diacylglycerol-mediated insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Control of oxidative metabolism and oxygen delivery in human skeletal muscle: a steady-state analysis of the work/energy cost transfer function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Short-term exercise training does not stimulate skeletal muscle ATP synthesis in relatives of humans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Impaired mitochondrial function and insulin resistance of skeletal muscle in mitochondrial diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Skeletal muscle energetics with PNMR: personal views and historic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Dynamic MRS and MRI of skeletal muscle function and biomechanics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Factors limiting maximal performance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Tissue variation in the control of oxidative phosphorylation: implication for mitochondrial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

The efficiency and plasticity of mitochondrial energy transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Pyruvate and citric acid cycle carbon requirements in isolated skeletal muscle mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

A discordance in rosiglitazone mediated insulin sensitization and skeletal muscle mitochondrial content/activity in Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Plasticity of skeletal muscle mitochondria: structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Assessment of mitochondrial energy coupling in vivo by 13C/31P NMR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Markers of mitochondrial biogenesis and metabolism are lower in overweight and obese insulin-resistant subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Metabolic control through the PGC-1 family of transcription coactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Mitochondrial dysfunction in the elderly: possible role in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Increased reactive oxygen species production and lower abundance of complex I subunits and carnitine palmitoyltransferase 1B protein despite normal mitochondrial respiration in insulin-resistant human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

The role of lipid accumulation in liver and muscle for insulin resistance and type 2 diabetes mellitus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Mechanism of free fatty acid-induced insulin resistance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Lipid-induced insulin resistance affects women less than men and is not accompanied by inflammation or impaired proximal insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Acute elevation of plasma lipids does not affect ATP synthesis in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Effect of short-term free Fatty acids elevation on mitochondrial function in skeletal muscle of healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Muscle acylcarnitines during short-term fasting in lean healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Excess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Compensatory increases in nuclear PGC1alpha protein are primarily associated with subsarcolemmal mitochondrial adaptations in ZDF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

High-fat diets cause insulin resistance despite an increase in muscle mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Effect of high-fat feeding on metabolic efficiency and mitochondrial oxidative capacity in adult rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Regulation of skeletal muscle mitochondrial fatty acid metabolism in lean and obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Measuring the acute effect of insulin infusion on ATP turnover rate in human skeletal muscle using phosphorus-31 magnetic resonance saturation transfer spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Liver fat in the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Mitochondrial abnormalities in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Nonalcoholic fatty liver disease: detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decoupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Body and liver fat mass rather than muscle mitochondrial function determine glucose metabolism in women with a history of gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Abnormal hepatic energy homeostasis in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Insulin resistance in the heart: studies on isolated cardiocytes of genetically obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Decreased high-energy phosphate ratios in the myocardium of men with diabetes mellitus type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Changes in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Evidence for a relationship between body mass and energy metabolism in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Brain energy metabolism during hypoglycaemia in healthy and type 1 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Cerebral glutamate metabolism during hypoglycaemia in healthy and type 1 diabetic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Adipocytes as regulators of energy balance and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Perspective: Does brown fat protect against diseases of aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Brown adipose tissue--a new role in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Brown adipose tissue activity controls triglyceride clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Reduced skeletal muscle mitochondrial respiration and improved glucose metabolism in nondiabetic obese women during a very low calorie dietary intervention leading to rapid weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Continuous low- to moderate-intensity exercise training is as effective as moderate- to high-intensity exercise training at lowering blood HbA(1c) in obese type 2 diabetes patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Exercise training increases mitochondrial content and ex vivo mitochondrial function similarly in patients with type 2 diabetes and in control individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Use of Dinitrophenol in Nutritional Disorders : A Critical Survey of Clinical Results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Regulation of skeletal muscle morphology in type 2 diabetic subjects by troglitazone and metformin: relationship to glucose disposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Resveratrol inhibits nonalcoholic fatty liver disease in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Functions and dysfunctions of mitochondrial dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Mitochondrial regulation of phosphocreatine/inorganic phosphate ratios in exercising human muscle: a gated 31P NMR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

31P nuclear magnetic resonance measurements of ATPase kinetics in aerobic Escherichia coli cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Quantitative ATP synthesis in human liver measured by localized 31P spectroscopy using the magnetization transfer experiment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Comparison of methods for measuring oxygen consumption in tumor cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

A high-throughput respirometric assay for mitochondrial biogenesis and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Insulin Signaling and Glucose Transport in Skeletal Muscle From First-Degree Relatives of Type 2 Diabetic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Lipid Infusion Decreases the Expression of Nuclear Encoded Mitochondrial Genes and Increases the Expression of Extracellular Matrix Genes in Human Skeletal Muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Increased subsarcolemmal lipids in type 2 diabetes: effect of training on localization of lipids, mitochondria, and glycogen in sedentary human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Mitochondrial impairment of human muscle in Friedreich ataxia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Family history of diabetes links impaired substrate switching and reduced mitochondrial content in skeletal muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Quantitative analysis by 31P magnetic resonance spectroscopy of abnormal mitochondrial oxidation in skeletal muscle during recovery from exercise

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Linear dependence of muscle phosphocreatine kinetics on oxidative capacity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Measurement of Ca2+ release in skinned fibers from skeletal muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Mitochondrial Respiration Is Decreased in Skeletal Muscle of Patients With Type 2 Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Mutation of mitochondrial DNA in livers from patients with alcoholic hepatitis and nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Abnormal left ventricular energy metabolism in obese men with preserved systolic and diastolic functions is associated with insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Outdoor temperature, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose-uptake activity of 18F-FDG-detected BAT in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Oxidative capacity and ageing in human muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Phosphocreatine hydrolysis by 31P-NMR at the onset of constant-load exercise in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.138

Insulin in the brain: a hormonal regulator of energy balance

31 March 2020

1 reference

12 December 2020

Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle

1 reference

12 December 2020

Lipid mediators of insulin resistance

1 reference

12 December 2020

Central insulin action regulates peripheral glucose and fat metabolism in mice

1 reference

12 December 2020

Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle

1 reference

12 December 2020

Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells

1 reference

12 December 2020

Comparison of measuring energy metabolism by different (31) P-magnetic resonance spectroscopy techniques in resting, ischemic, and exercising muscle

1 reference

12 December 2020

Hepatic ATP reserve and efficiency of replenishing: comparison between obese and nonobese normal individuals

1 reference

12 December 2020

Skeletal muscle mitochondrial dysfunction & diabetes.

1 reference

12 December 2020

Acid-linked functions of intermediates in oxidative phosphorylation. II. Experimental studies of the effect of pH upon respiratory, phosphorylative and transfer activities of liver and heart mitochondria

1 reference

12 December 2020

Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss.

1 reference

12 December 2020

Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2011.138

1 reference

25 August 2017

1 reference

PubMed ID

21912398